An Observational Study on the Identification of Prescription Patterns of STAFEN Cap
Recruiting
- Conditions
- Mixed Dyslipidemia
- Registration Number
- NCT06204380
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Brief Summary
An observational study on the identification of prescription patterns of STAFEN Cap., changes in blood lipid concentration, and statin-related muscle symptoms in Korean patients with mixed dyslipidemia
- Detailed Description
This study aims to observe the effectiveness of STAFEN capsule such as changes in blood lipid concentration and safety including statin-related muscle symptoms, and prescription patterns under daily clinical treatment in patients who have been prescribed STAFEN capsules for the treatment of complex dyslipidemia.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 4000
Inclusion Criteria
- Adults over 19 years of age
- A patient diagnosed with mixed dyslipidemia
- A patient who was first prescribed a STAFEN cap. for the purpose of treating mixed dyslipidemia according to the clinician's judgment
- A patient who voluntarily agreed in writing to this study
Exclusion Criteria
- Pregnant women, lactating women, or those planning to conceive
- A person who is prohibited from administering the STAFEN cap. under the permit
- If the person in charge of other clinical studies and the person in charge deems it inappropriate to be the subject of this clinical study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Target triglyceride rate at 6 months of STAFEN capsule prescription compared to baseline at 6 months of STAFEN capsule prescription compared to baseline Target triglyceride rate at 6 months of STAFEN capsule prescription compared to baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Delphoe Clinic
🇰🇷Gangneung-si, Korea, Republic of